rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Merck Kgaa

Rediff.com  »  News  »   Merck Kgaa

  News for Merck Kgaa

  • Business

Merck eyes Indian drug biggie, brands

Germany-based Merck KGaA, the world's oldest multinational pharmaceutical company, is eyeing to acquire a prominent Indian pharmaceutical company and established drug brands. This is part of......

'India is a growth story for us'

Germany-based pharma major Merck KGaA is targeting a five-fold increase in revenues from India over the next five years. The company, which bought biotech major Serono in 2007 to become a leading......

Ranbaxy to bid for $2.3 bn Merck arm

Ranbaxy Laboratories Ltd is eyeing German multinational Merck KGaA's $2.3-billion generic drug business. A deal will make the company the third largest generic drug manufacturer in the world, with......

Merck to conduct cancer vaccine trials in India

The German drug multinational, Merck KGaA, which received the Indian marketing approval for its head and neck cancer drug Erbitux last month,plans to conductfirst cancer vaccine trials in India.......

Glenmark licenses diabetes drug to Merck

Glenmark Pharmaceuticals is set to earn euro190 million (Rs 1,077.5 crore) from Merck KGaA by licensing the German major to develop a diabetes drug.The deal, which is being dubbed as another......
  Web results for Merck Kgaa
Juniper Pharmaceuticals Reports First Quarter 2016 Financial Results

/PRNewswire/ --Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced... ...

http://in.advfn.com/p.php?pid=nmona&article=71348827
EMD Serono Expands Biopharmaceutical R&D Facility in Billerica, MA to Accelerate Innovation

Tuesday, May 03, 2016 EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in North America, today announced a $12... ...

http://www.pharmafocusasia.com/news/emd-serono-expands-biopharmaceutical-r-d-facility-in-billerica
ABLYNX REPORTS POSITIVE TOP LINE RESULTS FOR ITS INHALED ANTI-RSV NANOBODY (ALX-0171) IN A PHASE I/IIa STUDY IN INFANTS HOSPITALISED WITH AN RSV INFECTION

GlobeNewswire 2016-05-03 -- Primary endpoint of safety and tolerability met -- Anti-viral effect demonstrated and encouraging initial... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=117289
ABLYNX ANNOUNCES MILESTONE IN DRUG DISCOVERY COLLABORATION

Comments April 29, 2016 - London Second Nanobody® targeting a G-protein-coupled receptor (GPCR) enters clinical development Further positive... ...

http://andhranews.net/Business/2016/ABLYNX-ANNOUNCES-MILESTONE-IN-DRUG-DISCOVERY-17102.htm
Separation Systems for Commercial Biotechnology Market to reach US$ 19,227.8 Mn in 2023

Transparency Market Research Report Added "Separation Systems for Commercial Biotechnology Market - Global Industry Analysis, Trends and Forecast... ...

http://pressreleaseping.com/separation-systems-commercial-biotechnology-market-reach-us-192278-mn-2023

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


merck kgaa
Merck KGaA v. Integra Lifesciences I,...


0 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z